{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:47:50Z","timestamp":1791888470171,"version":"4.3.4"},"reference-count":56,"publisher":"Keio Journal of Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio j. med","Keio J. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2302\/kjm.2016-0017-ir","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T22:09:11Z","timestamp":1493330951000},"page":"57-64","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Serum Therapy: Benefits, Cautions, and Potential Applications"],"prefix":"10.2302","volume":"66","author":[{"given":"Toru","family":"Hifumi","sequence":"first","affiliation":[{"name":"Emergency Medical Center, Kagawa University Hospital, Kagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Biosafety, National Institute of Infectious Disease, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ato","sequence":"additional","affiliation":[{"name":"Department of Immunology, National Institute of Infectious Disease, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Sawabe","sequence":"additional","affiliation":[{"name":"Department of Medical Entomology, National Institute of Infectious Disease, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Morokuma","sequence":"additional","affiliation":[{"name":"The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Morine","sequence":"additional","affiliation":[{"name":"Okinawa Prefectural Institute of Health and Environment, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Fukuoka City Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakai","sequence":"additional","affiliation":[{"name":"The Japan Snake Institute, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tokyo Bay Urayasu\/Ichikawa Medical Center, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","unstructured":"1. Park WH: Serum therapy. Bull N Y Acad Med 1931; 7: 401\u2013411. PMID:19311788"},{"key":"2","unstructured":"2. Von Behring EK: Ueber das zustandekommen der diphtherie-immunit\u00e4t und der tetanus-immunit\u00e4t bei thieren. Deutsche Medicininis-che Wochenschrift 1890; 49: 1113\u20131114."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Winau F, Winau R: Emil von Behring and serum therapy. Microbes Infect 2002; 4: 185\u2013188. PMID:11880051, DOI:10.1016\/S1286-4579(01)01526-X","DOI":"10.1016\/S1286-4579(01)01526-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ, International Scientific and Technical Committee: Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999; 179(Suppl 1): S18\u2013S23. PMID:9988160, DOI:10.1086\/514298","DOI":"10.1086\/514298"},{"key":"5","unstructured":"5. Schumacher J: [Nobel prize winners in physiology and medicine, 1901-50]. Munch Med Wochenschr 1951; 93: 1272\u20131275. PMID:14863332"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Nakai K, Takahashi M, Tomita M: The equine antitoxins supply system for biological poisons in Japan. Toxicon 2003; 42: 561\u2013562. PMID:14529739, DOI:10.1016\/S0041-0101(03)00232-0","DOI":"10.1016\/S0041-0101(03)00232-0"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Hifumi T, Murakawa M, Sakai A, Ginnaga A, Yamamoto A, Ato M, Kato H, Koido Y, Kawakita K, Hagiike M, Kuroda Y: Potentially fatal coagulopathy secondary to yamakagashi (Rhabdophis tigrinus) bites that completely recovered with antivenom treatment. Acute Medicine & Surgery 2015; 2: 123\u2013126. DOI:10.1002\/ams2.69","DOI":"10.1002\/ams2.69"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Silva A, Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, Ginnaga A, Kato H, Koido Y, Inoue J, Abe Y, Kawakita K, Hagiike M, Kuroda Y: Rhabdophis tigrinus is not a pit viper but its bites result in venom-induced consumptive coagulopathy similar to many viper bites. J Intensive Care 2014; 2: 43. PMID:25520845, DOI:10.1186\/s40560-014-0043-6","DOI":"10.1186\/s40560-014-0043-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hifumi T,Takahashi M, Morokuma K, Haraguchi Y, Kato H, Koido Y: Do you know the Clostridium perfringens antitoxin? J Jpn Soc intensive Care Med 2010; 17: 287\u2013289.","DOI":"10.3918\/jsicm.17.287"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Hifumi T, Koido Y: Tetanus associated with the Great East Japan Earthquake. J Jpn Soc Intensive Care Med 2013; 20: 355\u2013357. DOI:10.3918\/jsicm.20.355","DOI":"10.3918\/jsicm.20.355"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Hifumi T, Fujimi S, Yamagishi T, Arai S, Sawabe K, Yamamoto A, Ato M, Shibayama K, Ginnaga A, Kiriu N, Kato H, Koido Y, Inoue J, Kishikawa M, Abe Y, Kawakita K, Hagiike M, Kuroda Y: Clinical characteristics of redback spider bites. J Intensive Care 2014; 2: 62. PMID:25705418, DOI:10.1186\/s40560-014-0062-3","DOI":"10.1186\/s40560-014-0062-3"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hifumi T, Taki H, Yamamoto A, Ato M, Koido Y, Kuroda Y: Update of antivenom supply for redback spider bites in Japan. J Intensive Care 2015; 3: 7. PMID:25705432, DOI:10.1186\/s40560-014-0070-3","DOI":"10.1186\/s40560-014-0070-3"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Hifumi T, Sakai A, Kondo Y, Yamamoto A, Morine N, Ato M, Shibayama K, Umezawa K, Kiriu N, Kato H, Koido Y, Inoue J, Kawakita K, Kuroda Y: Venomous snake bites: clinical diagnosis and treatment. J Intensive Care 2015; 3: 16. PMID:25866646, DOI:10.1186\/s40560-015-0081-8","DOI":"10.1186\/s40560-015-0081-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nuchpraryoon I, Garner P: Interventions for preventing reactions to snake antivenom. Cochrane Database Syst Rev 2000; CD002153. PMID:10796682","DOI":"10.1002\/14651858.CD002153"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Isbister GK, Brown SG, MacDonald E, White J, Currie BJ, Australian Snakebite Project Investigators: Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 2008; 188: 473\u2013476. PMID:18429716","DOI":"10.5694\/j.1326-5377.2008.tb01721.x"},{"key":"16","unstructured":"16. Takazawa K, Otsuka H, Nakagawa Y, Inokuchi S: Clinical features of non-clostridial gas gangrene and risk factors for in-hospital mortality. Tokai J Exp Clin Med 2015; 40: 124\u2013129. PMID:26369267"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Brucato MP, Patel K, Mgbako O: Diagnosis of gas gangrene: does a discrepancy exist between the published data and practice? J Foot Ankle Surg 2014; 53: 137\u2013140. PMID:24345706, DOI:10.1053\/j.jfas.2013.10.009","DOI":"10.1053\/j.jfas.2013.10.009"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Takahira N, Shindo M, Tanaka K, Soma K, Ohwada T, Itoman M: Treatment outcome of nonclostridial gas gangrene at a level 1 trauma center. J Orthop Trauma 2002; 16: 12\u201317. PMID:11782626, DOI:10.1097\/00005131-200201000-00003","DOI":"10.1097\/00005131-200201000-00003"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ito M, Takahashi N, Saitoh H, Shida S, Nagao T, Kume M, Kameoka Y, Tagawa H, Fujishima N, Hirokawa M, Tazawa H, Minato T, Yamada S, Sawada K: Successful treatment of necrotizing fasciitis in an upper extremity caused by Clostridium perfringens after bone marrow transplantation. Intern Med 2011; 50: 2213\u20132217. PMID:21963743, DOI:10.2169\/internalmedicine.50.5829","DOI":"10.2169\/internalmedicine.50.5829"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Daly JJ, Haeusler MN, Hogan CJ, Wood EM: Massive intravascular haemolysis with T-activation and disseminated intravascular coagulation due to clostridial sepsis. Br J Haematol 2006; 134: 553. PMID:16822287, DOI:10.1111\/j.1365-2141.2006.06177.x","DOI":"10.1111\/j.1365-2141.2006.06177.x"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Hifumi T, Koido Y, Takahashi M, Yamamoto A: Antitoxin treatment for liver abscess caused by Clostridium perfringens. Clin Mol Hepatol 2013; 19: 97\u201398. PMID:23593617, DOI:10.3350\/cmh.2013.19.1.97","DOI":"10.3350\/cmh.2013.19.1.97"},{"key":"22","unstructured":"22. van Bunderen CC, Bomers MK, Wesdorp E, Peerbooms P, Veenstra J: Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature. Neth J Med 2010; 68: 343\u2013346. PMID:20876913"},{"key":"23","unstructured":"23. Diphtheria as of 2006 Japan. 2006 [cited 2017 2\/18]; Available from: http:\/\/idsc.nih.go.jp\/iasr\/27\/322\/tpc322.html."},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tiwari TS, Golaz A, Yu DT, Ehresmann KR, Jones TF, Hill HE, Cassiday PK, Pawloski LC, Moran JS, Popovic T, Wharton M: Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008; 46: 395\u2013401. PMID:18181738, DOI:10.1086\/525262","DOI":"10.1086\/525262"},{"key":"25","unstructured":"25. Prevention CfDCa. Respiratory diphtheria caused by Corynebacterium ulcerans 1997 [cited 2017 2\/18]; Available from: https:\/\/www.cdc.gov\/Mmwr\/Preview\/Mmwrhtml\/00051752.htm."},{"key":"26","unstructured":"26. Ministry of Health Labour and Welfare: Treatment of C. ulcerans. 2009 [cited 2017 2\/18]; Available from: http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kekkaku-kansenshou18\/corynebacterium_02.html."},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Yiannakopoulou E: Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology 2015; 95: 65\u201369. PMID:25613637, DOI:10.1159\/000370245","DOI":"10.1159\/000370245"},{"key":"28","unstructured":"28. Clostridium botulinum infection. 2008 [cited 2017 2\/18]; Available from: http:\/\/idsc.nih.go.jp\/iasr\/29\/336\/inx336-j.html."},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA: Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984; 76: 794\u2013798. PMID:6720725, DOI:10.1016\/0002-9343(84)90988-4","DOI":"10.1016\/0002-9343(84)90988-4"},{"key":"30","unstructured":"30. WHO: Botulism in Thailand. 2006 [cited 2017 2\/18]; Available from: http:\/\/www.who.int\/csr\/don\/2006_03_22a\/en\/."},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Rainey GJ, Young JA: Antitoxins: novel strategies to target agents of bioterrorism. Nat Rev Microbiol 2004; 2: 721\u2013726. PMID:15372082, DOI:10.1038\/nrmicro977","DOI":"10.1038\/nrmicro977"},{"key":"32","unstructured":"32. Cases and deaths from tetanus in Japan, 1999\u20132008. Infectious Disease Surveillance Center 2009; Available from: http:\/\/idsc.nih.go.jp\/iasr\/30\/349\/graph\/t3491.gif."},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Hifumi T, Yamamoto A, Takahashi M, Koido Y, Kawakita K, Kuroda Y: Considerations for tetanus infection in an adult with a protective tetanus antibody level. Am J Emerg Med 2014; 32: 1125. PMID:25027203, DOI:10.1016\/j.ajem.2014.06.008","DOI":"10.1016\/j.ajem.2014.06.008"},{"key":"34","unstructured":"34. Center ID: Tetanus in Japan as of 2001. 2002; 23:[Available from: http:\/\/idsc.nih.go.jp\/iasr\/23\/263\/tpc263.html."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Vollman KE, Acquisto NM, Bodkin RP: A case of tetanus infection in an adult with a protective tetanus antibody level. Am J Emerg Med 2014; 32: 392 e393-394.","DOI":"10.1016\/j.ajem.2013.10.025"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Okada K, Ueda K, Morokuma K, Kino Y, Tokugawa K, Nishima S: Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program. Jpn J Infect Dis 2004; 57: 67\u201371. PMID:15118214","DOI":"10.7883\/yoken.JJID.2004.67"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Takahashi M, Komiya T, Fukuda T, Nagaoka Y, Ishii R, Goshima F, Arimoto H, Kaku H, Nakajima N, Goshima T, Katoh T: A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in Japan. Jpn J Med Sci Biol 1997; 50: 87\u201395. PMID:9559444, DOI:10.7883\/yoken1952.50.87","DOI":"10.7883\/yoken1952.50.87"},{"key":"38","unstructured":"38. Dajani NA, Scheifele D: How long can we expect pertussis protection to last after the adolescent booster dose of tetanus-diphtheria-pertussis (Tdap) vaccines? Paediatr Child Health 2007; 12: 873\u2013874. PMID:19043506"},{"key":"39","unstructured":"39. Tetanus in Japan as of December 2008. 2008; Available from: http:\/\/idsc.nih.go.jp\/iasr\/30\/349\/tpc349.html."},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Weston WM, Friedland LR, Wu X, Howe B: Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(\u00ae)): results of two randomized trials. Vaccine 2012; 30: 1721\u20131728. PMID:22212127, DOI:10.1016\/j.vaccine.2011.12.055","DOI":"10.1016\/j.vaccine.2011.12.055"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Hifumi T, Yamamoto A, Morokuma K, Okada I, Kiriu N, Ogasawara T, Hasegawa E, Kato H, Inoue J, Koido Y, Takahashi M: Clinical efficacy of antivenom and cepharanthine for the treatment of Mamushi (Gloydius blomhoffii) bites in tertiary care centers in Japan. Jpn J Infect Dis 2013; 66: 26\u201331. PMID:23429081, DOI:10.7883\/yoken.66.26","DOI":"10.7883\/yoken.66.26"},{"key":"42","unstructured":"42. Hifumi T: Treatments of venomous snake bites. Nihon Iji Shinpo 2015; 4772: 56."},{"key":"43","unstructured":"43. Environment OPIoHa: [ 3 October 2014]; Available from: http:\/\/www.pref.okinawa.jp\/site\/hoken\/eiken\/syoho\/documents\/49-p81-83.pdf."},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Nishimura H, Enokida H, Kawahira S, Kagara I, Hayami H, Nakagawa M: Acute kidney injury and rhabdomyolysis after Protobothrops flavoviridis bite: a retrospective survey of 86 patients in a tertiary care center. Am J Trop Med Hyg 2016; 94: 474\u2013479. PMID:26643529, DOI:10.4269\/ajtmh.15-0549","DOI":"10.4269\/ajtmh.15-0549"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Wakisaka I, Miyashita M, Ando T, Takano A: An epidemiological study of habu-bites in the Amami Islands. Nippon Eiseigaku Zasshi 1978; 33: 606\u2013613. PMID:731999, DOI:10.1265\/jjh.33.606","DOI":"10.1265\/jjh.33.606"},{"key":"46","unstructured":"46. Study of the effectiveness of habu antivenom. Annual Report of Okinawa Prefeclural Institute of Health and Environment ."},{"key":"47","unstructured":"47. Nozaki MY, Hokama Z: Study of the effectiveness of antivenom for Okinawa habu (IX), Okinawa habu antivenom production research report (III)1978."},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Komori K, Konishi M, Maruta Y, Toriba M, Sakai A, Matsuda A, Hori T, Nakatani M, Minamino N, Akizawa T: Characterization of a novel metalloproteinase in Duvernoy\u2019s gland of Rhabdophis tigrinus tigrinus. J Toxicol Sci 2006; 31: 157\u2013168. PMID:16772705, DOI:10.2131\/jts.31.157","DOI":"10.2131\/jts.31.157"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Morokuma K, Kobori N, Fukuda T, Uchida T, Sakai A, Toriba M, Ohkuma K, Nakai K, Kurata T, Takahashi M: Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus). Jpn J Infect Dis 2011; 64: 397\u2013402. PMID:21937821","DOI":"10.7883\/yoken.64.397"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, Kato H, Koido Y, Inoue J, Abe Y, Kawakita K, Hagiike M, Ginnaga A, Kuroda Y: Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites. J Intensive Care 2014; 2: 44. PMID:25520846, DOI:10.1186\/s40560-014-0044-5","DOI":"10.1186\/s40560-014-0044-5"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Dart RC, McNally J: Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med 2001; 37: 181\u2013188. PMID:11174237, DOI:10.1067\/mem.2001.113372","DOI":"10.1067\/mem.2001.113372"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52. Alexi-Meskishvili V, Stiller B, Koster A, B\u00f6ttcher W, H\u00fcbler M, Photiadis J, Lange PE, Hetzer R: Correction of congenital heart defects in Jehovah\u2019s Witness children. Thorac Cardiovasc Surg 2004; 52: 141\u2013146. PMID:15192773, DOI:10.1055\/s-2004-820868","DOI":"10.1055\/s-2004-820868"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Isbister GK, Page CB, Buckley NA, Fatovich DM, Pascu O, MacDonald SP, Calver LA, Brown SG: Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study. Ann Emerg Med 2014; 64: 620\u2013628 e622.","DOI":"10.1016\/j.annemergmed.2014.06.006"},{"key":"54","unstructured":"54. Braitberg G, Segal L: Spider bites - assessment and management. Aust Fam Physician 2009; 38: 862\u2013867. PMID:19893831"},{"key":"55","doi-asserted-by":"publisher","unstructured":"55. Graudins A, Padula M, Broady K, Nicholson GM: Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms. Ann Emerg Med 2001; 37: 154\u2013160. PMID:11174232, DOI:10.1067\/mem.2001.113033","DOI":"10.1067\/mem.2001.113033"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56. Daly FF, Hill RE, Bogdan GM, Dart RC: Neutralization of Latrodectus mactans and L. hesperus venom by redback spider (L. hasseltii) antivenom. J Toxicol Clin Toxicol 2001; 39: 119\u2013123. PMID:11407496, DOI:10.1081\/CLT-100103826","DOI":"10.1081\/CLT-100103826"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/66\/4\/66_2016-0017-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:53:32Z","timestamp":1750208012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/66\/4\/66_2016-0017-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2016-0017-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}